
Skinive is a digital health company focused on AI-powered skin analysis. Their offerings include the Skinive app for home users and the Skinive MD app for clinicians, both designed to identify and assess over 50 skin conditions, including cancer risks. The technology utilizes computer vision and AI trained on a large database of clinical cases, providing users with pre-diagnosis and ongoing monitoring. Skinive aims to make skin tracking and primary diagnostics accessible globally via smartphones. Their apps are CE-Marked medical software, indicating compliance with medical device standards. The company reports over 500K satisfied users worldwide with an average rating of 4.8. Skinive also offers an API for developers to integrate their AI dermatology capabilities into other digital health and beauty applications.

Skinive is a digital health company focused on AI-powered skin analysis. Their offerings include the Skinive app for home users and the Skinive MD app for clinicians, both designed to identify and assess over 50 skin conditions, including cancer risks. The technology utilizes computer vision and AI trained on a large database of clinical cases, providing users with pre-diagnosis and ongoing monitoring. Skinive aims to make skin tracking and primary diagnostics accessible globally via smartphones. Their apps are CE-Marked medical software, indicating compliance with medical device standards. The company reports over 500K satisfied users worldwide with an average rating of 4.8. Skinive also offers an API for developers to integrate their AI dermatology capabilities into other digital health and beauty applications.
What they do: AI-powered skin analysis (consumer apps, clinician apps, API) for 50+ conditions
Regulatory status: CE‑marked medical software
Founded / HQ: Founded 2020; Amsterdam, Netherlands
Users / scale: Reports hundreds of thousands to millions of skin checks (500K+ users reported)
Latest funding: Non-equity assistance round announced 2022-12-11 (lead: Malta Enterprise)
Dermatology diagnostics, skin screening, teledermatology and mole monitoring.
2020
Digital health / Medical software
Latest listed round per company records
Earlier grant support listed
“Reported investors include Malta Enterprise and the European Network of AI Excellence Centres”